A synthetic peptide for use as a blocking control in assays to test for specificity of SLC22 A11 antibody, Alternative Names: SLC22A11 control peptide, SLC22A11 antibody Blocking Peptide, Anti-SLC22A11 Blocking Peptide, Solute Carrier Family 22 Member 11 Blocking Peptide, Organic Anion/Urate Transporter 11 Blocking Peptide, MGC34282 Blocking Peptide, OAT4 Blocking Peptide, hOAT4 Blocking Peptide, SLC22A11, SLCA11-22, SLCA11 22, SLCA11-22 Blocking Peptide, SLCA11 22 Blocking Peptide
SLC22A11
Reaktivität: Human
Wirt: Synthetic
BP, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SLC22A11
(Solute Carrier Family 22 (Organic Cation Transporter), Member 11 (SLC22A11))
Synonyme
DKFZp469L1732 Peptide, OAT4 Peptide, hOAT4 Peptide, solute carrier family 22 member 11 Peptide, solute carrier family 22 member 24 Peptide, SLC22A11 Peptide, LOC100349650 Peptide
Hintergrund
SLC22A11 is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. SLC22A11 is an integral membrane protein and is found mainly in the kidney and in the placenta, where it may act to prevent potentially harmful organic anions from reaching the fetus.